Effect of probenecid on the natriuresis and renin release induced by bumetanide in man.
In a randomized crossover trial in six normal male subjects, the effect of pretreatment with probenecid on natriuresis and renin release in response to bumetanide was studied. The subjects received 120 mEq sodium and 80 mEq potassium per day. A single dose of 2 mg bumetanide was administered on the fourth morning after pretreatment with either placebo or probenecid. Creatinine and uric acid were measured in serum and urine, plasma renin activity was determined by radioimmunoassay of angiotensin I, and plasma and urine concentrations of bumetanide were measured by a highly sensitive radioimmunoassay method. Probenecid reduced both natriuresis and hyperreninemia induced by bumetanide. This effect is postulated to be due not to a direct action on sodium excretion but is probably secondary to inhibition of renal tubular secretion of bumetanide. Consequently, these findings appear to support the concept that the quantity of bumetanide delivered to the tubular lumen is an important determinant of its diuretic effect.
D000328:Adult; D002034:Bumetanide / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000494:pharmacology*; D002986:Clinical Trials as Topic; D004232:Diuretics / Q000494:pharmacology*; D006801:Humans; D008297:Male; D009318:Natriuresis / Q000187:drug effects*; D011339:Probenecid / Q000494:pharmacology*; D011897:Random Allocation; D012083:Renin / Q000378:metabolism*
D004232:Diuretics; D002034:Bumetanide; D012083:Renin; D011339:Probenecid